Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Ashton-Rickardt Philip Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 4 Ashton-Rickardt Philip (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 8,845 options to buy @ $0.75, valued at $6.6k
03/01/2023 4 Ashton-Rickardt Philip (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 115,000 options to buy @ $1.09, valued at $125.4k
02/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2022 4 Ashton-Rickardt Philip (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 90,000 options to buy @ $3.03, valued at $272.7k
07/02/2021 4 Ashton-Rickardt Philip (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 90,000 options to buy @ $10.61, valued at $954.9k
06/14/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy